Harrisburg, NC -- (SBWIRE) -- 10/23/2020 -- The Acne (Medication and Therapeutic Devices) Treatment Market report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. We analyzed the impact of COVID-19 (Corona Virus) on the product industry chain based on the upstream and downstream markets, on various regions and major countries and on the future development of the industry are pointed out.
Order a Copy of This Report (USD $850) at:
https://www.marketinsightsreports.com/report/purchase/04282009437?mode=su?source=Releasewire&Mode=12
The 75 pages report presents the market competitive landscape and a corresponding detailed analysis of the major vendor/key players in the market. Top Companies in the Global Acne (Medication and Therapeutic Devices) Treatment Market: Bausch Health Companies Inc. (Formerly Valeant Pharmaceuticals International, Inc.), Nestle (Galderma S.A.), Allergan (Actavis Plc) and others.
Industry News and Updates:
Bausch Health Launches ALTRENO™ (tretinoin) Lotion, 0.05% In The United States
Oct 30, 2018: LAVAL, Quebec, -- Bausch Health Companies Inc. (NYSE/TSX: BHC) and its dermatology business, Ortho Dermatologics, one of the largest prescription dermatology health care businesses, today announced the U.S. launch of ALTRENOTM (tretinoin) Lotion, 0.05% for the topical treatment of acne vulgaris in patients 9 years of age and older. ALTRENO Lotion is the first and only tretinoin available in a lotion for acne. ALTRENO Lotion has been shown to be effective and generally well-tolerated, and is provided in a formulation with known moisturizers hyaluronic acid, glycerin and collagen.
The U.S. Food and Drug Administration approved ALTRENO Lotion on Aug. 24, 2018, based on data from two identical multicenter, randomized, double-blind, vehicle-controlled Phase 3 studies that demonstrated ALTRENO Lotion resulted in statistically significant reductions in both inflammatory and non-inflammatory lesions compared to vehicle. In the studies, ALTRENO Lotion was shown to have significantly greater efficacy compared to vehicle in achieving treatment success, which was defined as at least a two-grade improvement from baseline and clear to almost clear in acne severity by Evaluator Global Severity Score (EGSS). The most common adverse reactions, occurring in >1% of subjects and greater than vehicle, were dryness, pain, erythema, irritation and exfoliation.
FDA Approves Ortho Dermatologics' ARAZLOTM (Tazarotene) Lotion, 0.045%, For Acne Vulgaris
BRIDGEWATER, N.J., Dec. 19, 2019 -- Bausch Health Companies Inc. (NYSE/TSX: BHC) and its dermatology business, Ortho Dermatologics, one of the largest prescription dermatology health care businesses, today announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application for ARAZLOTM (tazarotene) Lotion, 0.045%, for the topical treatment of acne vulgaris in patients nine years of age and older.1 ARAZLO is the first tazarotene acne treatment available in a lotion form, and has been shown to provide strong efficacy with favorable tolerability.
Retinoids like tazarotene are a core component of acne treatment. However, a common barrier to their use is that treatment with retinoids is often associated with skin irritation, such as dryness.2 In a head-to-head study, ARAZLO demonstrated similar efficacy as Tazorac (tazarotene) Cream 0.1% with about half the adverse events.2 The most frequent adverse events reported with ARAZLO (?1%) were application site pain, dryness, exfoliation, erythema and pruritus.
Almirall brings new drug to stagnant US acne market
11 October 2018: On October 2, the FDA approved Seysara (sarecycline) for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients ages nine and older. Seysara was originally developed by Paratek Pharmaceuticals.
The company exclusively licensed US development and commercialisation rights to Allergan and retains the development and commercialisation rights to Seysara for the rest of the world. Almirall recently acquired Allergan's Medical Dermatology portfolio, and now has the rights to Seysara in the US. Seysara is a once-daily, oral, narrow spectrum tetracycline-derived antibiotic with anti-inflammatory properties. The arrival of this drug will somewhat shake up the currently stagnant and genericised acne market due to its ease of administration and once-daily formulation.
Acne vulgaris (acne) is currently one of the most common and well-established dermatology conditions, affecting around 90% of the world's population at some point in their lifetime. The disease is a chronic inflammatory dermatological condition of the pilosebaceous glands of the skin with a multifactorial pathogenesis.
Executive Summary:
Acne is a disorder of the skin that is caused by inflammation of the skin glands and hair follicles and is characterized by comedones and pimples specifically in certain areas like on the face, back and chest etc. During acne, sebaceous glands become clogged and infected which result in the formation of acne. It is most commonly found in teenagers and adolescents but also occurs in infants and adults. Depending on its severity, acne can cause emotional distress and scar the skin. Acne Vulgaris is the medical term for common acne. Acne can be mild, moderate or severe.
There are four main causes of acne vulgaris: hyper-keratinization, excess sebum production, bacteria Propionibacterium and inflammation. Dermatologists have the most experience treating different types of acne. There are six types of acne: Acne Rosacea, Acne Cosmetica, Acne Fulminans, Acne Keloidalis Nuchae (AKN), Acne Chloracne and Acne Medicamentosa. Several treatments are available in the market nowadays with effective results. Acne can be treated through three therapies namely systematic therapy, topical therapy and physical therapy. Currently acne treatment market is dominated by topical therapy or topical drugs that are widely used by large number of population for acne treatment.
The global acne treatment market has shown upward trends over the past few years and projections are made that the market would grow at a steady pace over the forecasted period (2019-2023) also. Global acne treatment market is supported by a number of growth drivers such as rising disposable income, high global prevalence rate of acne, unhealthy eating habits, adoption of various less painful aesthetic combination therapy procedures etc. Yet, there are certain challenges such as entry of generic drugs, safety issue regarding products, increasing acceptance of ant-acne treatment, etc. that hinder the growth of the market. Some of the latest trends related to the Acne treatment market that have been captured in this report are efforts like acquisitions and collaboration by relevant players to expand their presence and scope of Artificial Intelligence (AI) technology within the Acne treatment market.
The research study evaluates the overall size of the market, by making use of a bottom-up approach, wherein data for different industry verticals, and end-user industries and its applications across various product types have been recorded and predicted during the forecast period. These segments and sub-segments have been documented from the industry specialists and professionals, as well as company representatives, and are outwardly validated by analyzing previous years' data of these segments and sub-segments for getting an accurate and complete market size.
Inquire More:
https://www.marketinsightsreports.com/reports/04282009437/global-acne-medication-and-therapeutic-devices-treatment-market-size-trends-forecasts-2019-2023-edition/inquiry?source=Releasewire&Mode=12
Following are major Table of Content of Acne (Medication and Therapeutic Devices) Treatment Industry:
- Acne (Medication and Therapeutic Devices) Treatment Market Sales Overview.
- Acne (Medication and Therapeutic Devices) TreatmentMarket Sales Competition by Manufacturers.
- Acne (Medication and Therapeutic Devices) Treatment Market Sales Analysis by Region.
- Acne (Medication and Therapeutic Devices) Treatment Market Sales Analysis by Type.
- Acne (Medication and Therapeutic Devices) Treatment Market Analysis by Application.
- Acne (Medication and Therapeutic Devices) TreatmentMarket -Manufacturers Analysis.
Furthermore, this study will help our clients solve the following issues:
Cyclical dynamics - We foresee dynamics of industries by using core analytical and unconventional market research approaches. Our clients use insights provided by us to maneuver themselves through market uncertainties and interferences.
Identifying key cannibalizes - Strong substitute of a product or service is the most important threat. Our clients can identify key cannibalizes of a market, by procuring our research. This helps them in aligning their new product development/launch strategies in advance.
Spotting emerging trends – The report help clients to spot upcoming hot market trends. We also track possible impact and disruptions which a market would witness by a particular emerging trend. Our proactive analysis help clients to have early mover advantage.
Interrelated opportunities - This report will allow clients to make decisions based on data, thereby increasing the chances that the strategies will perform better if not best in real world.
Browse the report description and TOC:
https://www.marketinsightsreports.com/reports/04282009437/global-acne-medication-and-therapeutic-devices-treatment-market-size-trends-forecasts-2019-2023-edition?source=Releasewire&Mode=12
Customization of the Report: This report can be customized as per your needs for additional data up to 3 companies or countries or 40 analyst hours.
If you have any questions about any of our "Acne (Medication and Therapeutic Devices) Treatment market report" or would like to schedule a personalized free demo of Acne (Medication and Therapeutic Devices) Treatment market report, please do not hesitate to contact me at irfan@marketinsightsreports.com
Best wishes,
Irfan Tamboli
Head of Sales Operations
Market Insights Reports
Tel: + 1704 266 3234 | +91-750-707-8687
Email: sales@marketinsightsreports.com | irfan@marketinsightsreports.com
About MarketInsightsReports
MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. MarketInsightsReports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.